Financial Risk Management Unit (FRMU) The FRMU provides support with business issues relating to economic projects with a volume > 50,000 € according to the MHH third-party funding guideline. Consulti

01.06.2022 TACTiC – Tailored Application for individualized Cell Therapy with iPSC-derived Cardiomyocytes Preclinical evaluation in a non-human primate model and a roadmap for clinical application The

MD/PhD program Molecular Medicine Fully accreditated in 2009 as the first PhD program in Germany according to European standards (ECTS), the MD/PhD program features an interdisciplinary curriculum lea

Dr. Hristo Georgiev Institute of Immunology, OE 5240 I11-02-1120 Phone: +49 511 532 9729 E-Mail: Georgiev.Hristo @ mh-hannover.de Research Focus The basic research interest of our group includes the d

Chief of the Department Prof. Dr. med. Kai Schmidt-Ott Curriculum Vitae Prof. Dr. med. Kai Schmidt-Ott Prof. Dr. Kai Schmidt-Ott is Chief of the Department of Nephrology and Hypertension at Hannover M

Members of the Georgiev Group Hristo Georgiev Georgiev.Hristo @ mh-hannover.de Phone: +49 511 532 9729 Hristo is interested in investigating the mechanisms controlling development and differentiation

Completed Projects of the Georgiev Group 05/2018 – 04/2020 Research Stipends GE 3062/1-1 Deciphering endogenous and environmental factors impacting on development and function of iNKT cell subsets.

Dr. med. Zeynep Güner-Celebi Consultant transplant outpatient clinic E-Mail: Guener-Celebi.Zeynep @ mh-hannover.de

Application form Please complete the application form below. We will contact you and arrange an appointment for a training session. MHH users must complete domain name, OE, and Kostenstelle. Annotatio

01.09.2022 HEAL: HLA-homozygous iPSC-cardiomyocytE Aggregate manufacturing technologies for allogenic cell therapy to the heart EU funds research project HEAL in cell-based heart repair The European U